Evidence map›Paper›PMID 26258444›Full record

ArticlePloS one2015

Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation.

Ansgar Zoch, Steffen Mayerl, Alexander Schulz, Thomas Greither, Lucien Frappart, Juliane Rübsam, Heike Heuer, Marco Giovannini, Helen Morrison

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.International journal of molecular sciences · 2018
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ansgar ZochLeibniz Institute for Age Research-FLI Jena, Beutenbergstr. 11, D-07745 Jena, Germany.
Steffen MayerlLeibniz Institute for Age Research-FLI Jena, Beutenbergstr. 11, D-07745 Jena, Germany.
Alexander SchulzLeibniz Institute for Age Research-FLI Jena, Beutenbergstr. 11, D-07745 Jena, Germany.
Thomas GreitherCenter for Reproductive Medicine and Andrology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, D-06120 Halle (Saale), Germany.
Lucien FrappartLeibniz Institute for Age Research-FLI Jena, Beutenbergstr. 11, D-07745 Jena, Germany.
Juliane RübsamLeibniz Institute for Age Research-FLI Jena, Beutenbergstr. 11, D-07745 Jena, Germany.
Heike HeuerLeibniz Institute for Age Research-FLI Jena, Beutenbergstr. 11, D-07745 Jena, Germany; Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, D-40225 Düsseldorf, Germany.
Marco GiovanniniCenter for Neural Tumor Research and Section on Genetics of Hereditary Ear Disorders, House Research Institute, University of California Los Angeles, Los Angeles, CA 90057, United States of America.
Helen MorrisonLeibniz Institute for Age Research-FLI Jena, Beutenbergstr. 11, D-07745 Jena, Germany.
Leibniz Association · DEHouse Clinic · USMartin Luther University Halle-Wittenberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumour suppressor Merlin, encoded by the gene NF2, is frequently mutated in the autosomal dominant disorder neurofibromatosis type II, characterised primarily by the development of schwannoma and other glial cell tumours. However, NF2 is expressed in virtually all analysed human and rodent organs, and its deletion in mice causes early embryonic lethality. Additionally, NF2 encodes for two major isoforms of Merlin of unknown functionality. Specifically, the tumour suppressor potential of isoform 2 remains controversial. In this study, we used Nf2 isoform-specific knockout mouse models to analyse the function of each isoform during development and organ homeostasis. We found that both isoforms carry full tumour suppressor functionality and can completely compensate the loss of the other isoform during development and in most adult organs. Surprisingly, we discovered that spermatogenesis is strictly dependent on the presence of both isoforms. While the testis primarily expresses isoform 1, we noticed an enrichment of isoform 2 in spermatogonial stem cells. Deletion of either isoform was found to cause decreased sperm quality as observed by maturation defects and head/midpiece abnormalities. These defects led to impaired sperm functionality as assessed by decreased sperm capacitation. Thus, we describe spermatogenesis as a new Nf2-dependent process. Additionally, we provide for the first time in vivo evidence for equal tumour suppressor potentials of Merlin isoform 1 and isoform 2.

Indexed as

AnimalsBrain NeoplasmsCell SeparationFemaleFertilityFlow CytometryGene DeletionGenotypeIn Situ HybridizationLiverMaleMiceMice, Inbred C57BLMice, KnockoutMusclesNeoplasmsNeurofibromin 2Protein Isoforms

Identifiers

PMID26258444
PMCPMC4530865
OpenAlexW1896853061

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.